Your Health. Your Family. Your Choice.
Life Threatening? No
Write-up: Death; This is a spontaneous report from a contactable physician. This is a report received from the Agency. The regulatory authority report number is v21100370. A 62 and 11 month old year-old male patient received BNT162B2 (COMIRNATY; Lot Number: ER2659; Expiration Date: 30Jun2021), dose 2 via an unspecified route of administration on 01Apr2021, at 14:30 as single dose for covid-19 immunization. The patient''s medical history was not reported. The patient reported that he took unspecified oral antithrombotic drug. The patient had no family history. On 11Mar2021, the patient had received the 1st dose of BNT162B2 (Lot number EP2163, Expiration date 31May2021), and had no adverse reaction. The patient experienced death on 02Apr2021. The patient underwent lab tests and procedures which included body temperature: 36,4 Centigrade on 01Apr2021 before vaccination. Details were as follows: On 02Apr2021, in the morning (1 days after the vaccination), the patient died. The outcome of the event was fatal. On 01Apr2021, the day of the vaccination, the patient went home as no abnormality was noted. In the early morning of 02Apr2021, within 24 hours from the vaccination, his death was confirmed at home. The reporting physician classified the death as serious and assessed that the causality between the event and BNT162B2 as unassessable. The reporting physician considered the oral antithrombotic drug the patient reported as other possible causative factor for the event. The patient died on 02Apr2021. It was not reported if an autopsy was performed.; Reported Cause(s) of Death: Death
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166